Pathfinder Cell Therapy (Pathfinder Cell Therapy) Net Change in Cash : $-0.02 Mil (TTM As of Sep. 2015)

View and export this data going back to . Start your Free Trial

What is Pathfinder Cell Therapy Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Pathfinder Cell Therapy's Net Change in Cash for the three months ended in Sep. 2015 was $0.00 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2015 was $-0.02 Mil.

Pathfinder Cell Therapy Net Change in Cash Historical Data

The historical data trend for Pathfinder Cell Therapy's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pathfinder Cell Therapy Net Change in Cash Chart

Pathfinder Cell Therapy Annual Data

Trend

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Net Change in Cash

Get a 7-Day Free Trial

0.18

-0.19

0.03

-0.02

Pathfinder Cell Therapy Quarterly Data
	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15
Net Change in Cash	Get a 7-Day Free Trial															-	-	-	-0.02	-

Pathfinder Cell Therapy Net Change in Cash Calculation

Pathfinder Cell Therapy's Net Change in Cash for the fiscal year that ended in Dec. 2014 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-0.963	+	0	+	0.945	+	0
	=	-0.02

Pathfinder Cell Therapy's Net Change in Cash for the quarter that ended in Sep. 2015

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.178 + 0 + 0.182 + 0

= 0.00

Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pathfinder Cell Therapy Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Pathfinder Cell Therapy's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pathfinder Cell Therapy Inc (OTCPK:PFND) » Definitions » Net Change in Cash

Comparable Companies

CAPS BTHE GOVX LCAR ENTB ADYNF FPMI GLAG IMUC CTBO OPLI ERGO GNBT ICOTF TIKRF CLYXF CBBT WINT NSPX TLOG

Traded in Other Exchanges

N/A

Address

12 Bow Street, Cambridge, MA, USA, 02138

Website

http://www.pathfindercelltherapy.com

Pathfinder Cell Therapy Inc is a regenerative medicine company. It is engaged in developing novel cell-based and related therapies for the treatment of diabetes, renal diseases and medical conditions characterized by organ-specific cell damage. Further, the group has discovered a new mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells ("PCs") themselves being incorporated into the new tissue. Geographically the business activities are functioned through the region of United States.

Executives

John J Alam director 130 WAVERLY STREET, CAMBRIDGE MA 02139

John L Brooks director 100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090

Pathfinder Cell Therapy (Pathfinder Cell Therapy) Headlines

No Headlines

John J Alam	director	130 WAVERLY STREET, CAMBRIDGE MA 02139
John L Brooks	director	100 LOWDER BROOK DRIVE SUITE 2500, WESTWOOD MA 02090